Patents by Inventor Andrei Yurievitch Tauber

Andrei Yurievitch Tauber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor
    Patent number: 6767909
    Abstract: A compound, suitable as an alpha-2B-adrenoceptor antagoist, having a structure of formula (I) or a pharmaceutically acceptable salt thereof wherein R1, R2, R3, R4 and R5 are independently of each other H, a straight or branched alkyl or alkoxy group with 1 to 4 carbon atoms, or a halogen; X is H, a straight or branched alkyl chain with 1 to 4 carbon atoms, phenyl, —OH or ═O; Z is H, acetyl, —CH2—Ph—O—CF3 or —CH2—Ph—CF3, Y is a ring structure optionally linked to formula (I) with an alkyl chain having one or two carbon atoms. The compound is suitable for use in a method for treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor in a mammal.
    Type: Grant
    Filed: July 17, 2002
    Date of Patent: July 27, 2004
    Assignee: Oy Juvantia Pharma Ltd.
    Inventors: Topi Joutsamo, Andrei Yurievitch Tauber, Harri Salo, Anna-Maria Hoffrén, Siegfreid Wurster
  • Derivatives of quinoline as alpha-2 antagonists
    Publication number: 20030225078
    Abstract: A compound of formula I, 1
    Type: Application
    Filed: April 16, 2003
    Publication date: December 4, 2003
    Applicants: Orion Corporation, Oy Juvantia Pharma Ltd.
    Inventors: Siegfried Wurster, Mia Engstrom, Juha-Matti Savola, Iisa Hoglund, Jukka Sallinen, Antti Haapalinna, Andrei Yurievitch Tauber, Anna-Marja Katariina Hoffren, Harri Elias Salo
  • Dervatives of quinoline as alpha-2 antagonists
    Patent number: 6593324
    Abstract: A compound of formula I, wherein A, Ra, Rb, R1 to R5, m and t are as defined as disclosed, or a pharmaceutically acceptable salt or ester thereof, useful as an alpha-2 antagonist. The compounds I can be used for the treatment of diseases or conditions where alpha-2 antagonists are indicated to be effective.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: July 15, 2003
    Assignees: Orion Corporation, Oy Juvantia Pharma Ltd.
    Inventors: Siegfried Wurster, Mia Engström, Juha-Matti Savola, Iisa Höglund, Jukka Sallinen, Antti Haapalinna, Andrei Yurievitch Tauber, Anna-Marja Katariina Hoffrén, Harri Elias Salo
  • Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor
    Publication number: 20030073710
    Abstract: A compound, suitable as an alpha-2B-adrenoceptor antagoist, having a structure of formula (I) 1
    Type: Application
    Filed: July 17, 2002
    Publication date: April 17, 2003
    Inventors: Topi Joutsamo, Andrei Yurievitch Tauber, Harri Salo, Anna-Marja Hoffren, Siegfried Wurster
  • Derivatives of quinoline as alpha-2 antagonists
    Publication number: 20010046991
    Abstract: A compound of formula I, 1
    Type: Application
    Filed: February 28, 2001
    Publication date: November 29, 2001
    Inventors: Siegfried Wurster, Mia Engstrom, Juha-Matti Savola, Iisa Hoglund, Jukka Sallinen, Antti Haapalinna, Andrei Yurievitch Tauber, Anna-Marja Katariina Hoffren, Harri Elias Salo